Scinovex
Subscribe
P

Paul Emery

University of LeedsORCID https://orcid.org/0000-0002-7429-8482
h-index
—
Publications
—
Citations
—
i10-index
—
Impact (2-yr)
—

Top Publications

2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative
Arthritis & Rheumatism20109,412 citations
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
Annals of the Rheumatic Diseases20202,709 citations
Treating rheumatoid arthritis to target: recommendations of an international task force
Annals of the Rheumatic Diseases20102,076 citations
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update
Annals of the Rheumatic Diseases20131,756 citations
Rituximab for rheumatoid arthritis refractory to anti–tumor necrosis factor therapy: Results of a multicenter, randomized, double‐blind, placebo‐controlled, phase III trial evaluating primary efficacy and safety at twenty‐four weeks
Arthritis & Rheumatism20061,631 citations
Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force
Annals of the Rheumatic Diseases20151,431 citations
Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: A randomized, controlled trial
Arthritis & Rheumatism20041,165 citations
IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial
Annals of the Rheumatic Diseases20081,104 citationsFirst authorCorresponding
The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: Results of a phase IIB randomized, double‐blind, placebo‐controlled, dose‐ranging trial
Arthritis & Rheumatism20061,050 citationsFirst authorCorresponding
A simplified disease activity index for rheumatoid arthritis for use in clinical practice
Lara D. Veeken20031,048 citations
American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials
Arthritis & Rheumatism20111,015 citations
2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis
Annals of the Rheumatic Diseases2011979 citations
Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist
Arthritis & Rheumatism1998971 citations
The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal
Annals of the Rheumatic Diseases2009926 citations
European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update
Annals of the Rheumatic Diseases2016910 citations
Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA)
Annals of the Rheumatic Diseases2013848 citations
EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)
Annals of the Rheumatic Diseases2006797 citations
American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials
Annals of the Rheumatic Diseases2011766 citations
Psoriasis and Systemic Inflammatory Diseases: Potential Mechanistic Links between Skin Disease and Co-Morbid Conditions
Journal of Investigative Dermatology2010698 citations
A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis
Lara D. Veeken2000469 citationsFirst authorCorresponding
Paul Emery · Scinovex